Tag Prakash A. Patel

Shy-Drager Disease

Acknowledgment A sincere thanks to Drs. Brad J. Hymel and Don D. Doussan for their contribution to this chapter in the previous edition of this text. Risk More common in men than in women. Symptoms begin in fifth-seventh decades of…

Hematologic Risk Assessment

Hematologic risk assessment (HRA) involves evaluating and managing needs for red blood cell (RBC) transfusion as well as the integrity of a patient’s coagulation ability, including intrinsic bleeding disorders or coagulopathies and anticoagulant or antiplatelet medications. HRA is an essential…